Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1291-1300
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1291
Table 1 Comparison of the baseline characteristics of different groups of patients with ampullary adenocarcinoma, n (%)
Characteristic
Total (n = 233)
PNI-low (n = 100)
PNI-high (n = 133)
P value
GenderMale133 (57.1)56 (56.0)77 (57.9)0.772
Female100 (42.9)44 (44.0)56 (41.1)
Age, yr≤ 60141 (60.5)52 (52.0)89 (66.9)0.021
> 6092 (39.5)48 (48.0)44 (33.1)
Tumor size, cm≤ 2112 (48.1)42 (42.0)70 (52.6)0.108
> 2121 (51.0)58 (58.0)63 (47.4)
Tumor differentiationPoor differentiation88 (37.8)43 (43.0)45 (33.8)0.063
Moderate differentiation96 (41.2)43 (43.0)53 (39.8)
Well differentiation49 (21.0)14 (14.0)35 (26.4)
Lymph nodes resection< 17156 (67.0)64 (41.0)92 (59.0)0.406
≥ 1777 (33.0)36 (46.8)41 (53.2)
Vascular invasionNo182 (78.1)74 (74.0)108 (81.2)0.188
Yes51 (21.9)26 (26.0)25 (18.8)
pTT131 (13.3)13 (13.0)18 (13.5)0.8291
T286 (36.9)34 (34.0)52 (39.1)
T3110 (47.2)50 (50.0)60 (45.1)
T46 (2.6)3 (3.0)3 (2.3)
pNN0162 (69.5)64 (64.0)98 (73.7)0.193
N158 (24.9)28 (28.0)30 (22.6)
N213 (5.6)8 (8.0)5 (3.7)
TNM stageI97 (41.6)36 (36.0)61 (45.9)0.213
II65 (27.9)28 (28.0)37 (27.8)
III71 (30.5)36 (36.0)35 (26.3)
Postoperative complicationNo142 (60.9)40 (40.0)51 (38.3)0.798
Yes91 (39.1)60 (60.0)82 (61.6)
Postoperative adjuvant therapyNo152 (65.2)29 (29.0)34 (25.6)0.597
Yes63 (27.0)64 (64.0)88 (74.4)
Unknow18 (7.8)
CA199, U/mL≤ 59.67107 (45.9)38 (38.0)69 (51.9)0.053
> 59.67107 (45.9)52 (52.0)55 (48.1)
Unknow19 (8.2)
ALT, U/L≤ 52.0118 (50.6)47 (47.0)71 (53.4)0.335
> 52.0115 (49.4)53 (53.0)62 (46.6)
AST, U/L≤ 55.0122 (52.4)44 (44.0)78 (58.6)0.027
> 55.0111 (47.6)56 (56.0)55 (41.4)
TBIL, μmol/L≤ 51.3117 (50.2)42 (42.0)75 (56.4)0.030
> 51.3116 (49.8)58 (58.0)58 (43.6)
Cr, μmol/L≤ 62.0115 (49.4)61 (61.0)54 (40.6)0.002
> 62.0118 (50.6)39 (39.0)79 (59.4)